GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

The WHO has given a green light to widespread use of GlaxoSmithKline's malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The RTS,S/AS01 vaccine ...

The combination of climate change and pathogen expansion could be fueling a surge in infectious diseases. GEN consulted ...

GSK's former head of vaccines R&D – Dr Emmanuel Hanon – is heading up a new biotech called Vicebio that will go up against his former employer with a vaccine against respiratory syncytial ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

Discover the importance of vital statistics for a healthy society, India's role in chemotherapy drugs, and unresolved Covid ...

A University of California, Riverside-led team has made an advance in the basic understanding of Plasmodium falciparum, the ...